Pancreastatin Inhibition Alters the Colonic Epithelial Cells Profile in a Sex-Dependent Manner
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312757 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Diane M Tshikudi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0T5, Canada. Hauptthemen laut MEDLINE: Epithelial Cells, Colon, Mice, Inbred C57BL. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
The impaired mucosal barrier is a hallmark of ulcerative colitis (UC), an inflammatory colonic disorder with epidemiological and pathophysiology sex bias. UC Patients overexpress the colonic epithelial cells (CECs)-derived peptide pancreastatin (PST). Pancreastatin inhibitor 8 (PSTi8), an inhibitor of PST, has shown promising anti-inflammatory effects on UC. However, no data exist in the context of CEC barrier function and integrity. We investigated the impact of PSTi8 treatment on CECs in homeostatic and colitic conditions. PSTi8 (2.5 mg/mL/kg, i.r.) or PBS treatment started one day before colitis induction (5% dextran sodium sulfate for five days) in male and female C57BL/6 mice. The disease activity score was assessed daily. Epithelial-associated cytokines, markers specific to differentiation, proliferation, differentiated CECs, stem cells, CECs regulators, and the PSTi8 G-protein coupled receptor 78 (GPR78) signaling pathway, were evaluated using ELISA, immunofluorescence and qRT-PCR. PSTi8 treatment reduced the epithelial-associated cytokines and differentiated CECs while promoting CEC proliferation and self-renewal in females at a steady state through the GRP78 signaling pathway. PSTi8 treatment exacerbated colitis severity and increased CEC differentiation while reducing proliferation in colitic females. Conversely, PSTi8 treatment reduced males’ susceptibility to colitis by preserving stem cells and differentiated CECs. PST regulated colonic mucosal maintenance in a sex- and disease-dependent manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0T5, Canada.
- Children's Hospital Research Institute of Manitoba, University of Manitoba, Winnipeg, MB R3E 3P4, Canada.
- IBD Clinical and Research Centre, University of Manitoba, Winnipeg, MB R3A 1R9, Canada.
ORCID-Profile: Hannah Hutchison
Förderung
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Tshikudi, D. M., Hutchison, H., & Ghia, J. E. (2024). Pancreastatin Inhibition Alters the Colonic Epithelial Cells Profile in a Sex-Dependent Manner. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312757
Vancouver
Tshikudi DM, Hutchison H, Ghia JE. Pancreastatin Inhibition Alters the Colonic Epithelial Cells Profile in a Sex-Dependent Manner. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312757
BibTeX
@article{Tshikudi2024,
author = {Tshikudi, Diane M and Hutchison, Hannah and Ghia, Jean-Eric},
title = {Pancreastatin Inhibition Alters the Colonic Epithelial Cells Profile in a Sex-Dependent Manner},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312757}
}
EUVIMED